| Literature DB >> 25225716 |
Alberto Mendoza1, Leticia Albert1, Sylvia Belda2, Lidia Casanueva2, Dolores Herrera1, Miguel A Granados1, José M Velasco1, Enrique García1, Juan M Aguilar1, Juan V Comas1.
Abstract
Although mortality is low after the modified Fontan procedure, there is a significant percentage of patients with prolonged postoperative recovery. The objective of this study is to evaluate the usefulness of postoperative administration of oral sildenafil and inhaled nitric oxide on early postoperative outcome. A prospective interventional and comparison study with a historical cohort was conducted. Between January, 2010 and March, 2013, 16 patients received oral sildenafil during immediate modified Fontan postoperative period. Inhaled nitric oxide was also administered if the patient was kept intubated 12 hours after surgery. Early postoperative outcome was compared with a historical cohort of 32 patients on whom the modified Fontan procedure was performed between March, 2000 and December, 2009. Postoperative administration of sildenafil and nitric oxide had no influence on early postoperative outcome after the modified Fontan procedure in terms of duration of pleural effusions, mechanical ventilation time, length of stay in the ICU, and length of hospital stay.Entities:
Keywords: CHD; Modified Fontan operation; inhaled nitric oxide; pulmonary vasodilators; sildenafil
Mesh:
Substances:
Year: 2014 PMID: 25225716 DOI: 10.1017/S1047951114001772
Source DB: PubMed Journal: Cardiol Young ISSN: 1047-9511 Impact factor: 1.093